Last updated: May 29, 2026
Zegalogue (Zegalogue®) Suppliers: Who Makes the Dosing Pen and Components for dasiglucagon
Zegalogue is dasiglucagon, a glucagon analog in a prefilled autoinjector used for severe hypoglycemia rescue. Supplier mapping hinges on (1) the autoinjector device and its subcomponents, (2) dasiglucagon drug substance and drug product manufacturing, and (3) packaging and labeling. No complete supplier roster can be produced from the information available in this chat.
Who are the Zegalogue (dasiglucagon) drug manufacturers and contract suppliers?
Direct supplier lists for Zegalogue components are not available in the provided context. A complete answer requires confirmed, sourced information tying specific firms to:
- drug substance manufacture (dasiglucagon API or intermediate),
- finished drug product manufacture (dasiglucagon in the final strength and presentation),
- autoinjector assembly and device supply,
- primary packaging (cartridge/pen fill system) and secondary packaging.
What supply chain elements typically sit behind Zegalogue?
- Drug substance (API) manufacturing site(s)
- Drug product manufacturing site(s) for dasiglucagon formulation, fill-finish, and sterile handling (if applicable to the specific presentation)
- Device manufacturing (prefilled autoinjector platform)
- Component suppliers (needle, injector mechanism, springs, sensors, elastomeric parts)
- Packaging operations (pen labels, cartons, case pack, NDC/GTIN label control)
What companies supply the Zegalogue autoinjector device platform?
Zegalogue is a “prefilled autoinjector” product. Supplier identification for the device platform requires a source such as:
- FDA labeling “Manufactured for/By” lines,
- the device supplier disclosure in the US prescribing information,
- Orange Book/NDA manufacturing site listings,
- or regulatory submissions listing device manufacturing arrangements.
No such supplier-identifying facts are present in the supplied prompt.
Device platform questions that drive supplier selection
- Does the pen use a proprietary injector design or a standardized platform?
- Who supplies the needle and needle shield mechanism?
- Who performs final pen assembly, functional testing, and release?
Where does dasiglucagon (Zegalogue) API come from and who supplies it?
Dasiglucagon API supply depends on NDA/CMC details that link:
- API manufacturer identity and site,
- intermediate synthesis and purification vendors,
- and control of polymorph/impurity profiles.
No API supplier information is provided here.
What to look for in supplier documentation
- Labeling “manufactured by” entities
- NDA manufacturing site tables and ASMF linkages (if applicable)
- Inspection histories tied to the relevant CMC facility
What packaging and labeling suppliers support Zegalogue distribution?
Supplier identification for packaging and labeling typically comes from:
- “distributed by” and “packaged by” lines in labeling,
- contract packaging manufacturing lists in regulatory submissions,
- and barcode/serialization vendors where disclosed.
No packaging supplier facts are available in the provided context.
Key packaging sub-suppliers in autoinjector products
- Primary packaging (pen components, cartons, labels)
- Secondary packaging (outer cartons, hospital kits)
- Label control systems and serialization integration
Which suppliers produce Zegalogue in the US and for international markets?
Global supply chain varies by:
- label strengths and presentations,
- regulatory approvals by country,
- and site availability for fill-finish and device assembly.
No geographic supplier roster can be stated from the available input.
Market-by-market supplier mapping typically requires
- country-specific SmPC/leaflet labeling
- local manufacturer/distributor name disclosures
- local batch release and testing vendors where disclosed
How does Zegalogue’s supplier structure compare with other glucagon rescue products (Baqsimi, Gvoke)?
A credible comparison requires confirmed supplier identities for each product, including:
- device platform suppliers (for autoinjector vs nasal vs prefilled syringe formats),
- API sources,
- and contract manufacturing sites.
Without those facts for Zegalogue, a comparison cannot be completed.
What supplier risks matter for Zegalogue continuity of supply?
Supplier and manufacturing continuity hinges on:
- device component availability (springs, needles, shields),
- fill-finish capacity constraints,
- and regulatory quality system performance.
Risk statements require supplier facility identification to be actionable, which is not provided here.
Key Takeaways
- Zegalogue supplier mapping requires confirmed sources tying firms to drug substance, drug product, and autoinjector/device assembly.
- The prompt provides no supplier-identifying facts, so a complete and accurate supplier list cannot be produced.
- Actionable supplier due diligence for Zegalogue should be based on labeling/manufacturing site disclosures and device platform sourcing records.
FAQs
-
Who manufactures Zegalogue in the US?
Requires labeling “manufactured for/by” or NDA manufacturing site disclosures; not provided.
-
Which company supplies the Zegalogue autoinjector device?
Requires device platform identification from prescribing information or regulatory submissions; not provided.
-
Who is the API supplier for dasiglucagon?
Requires confirmed CMC/API manufacturer data; not provided.
-
Are there contract manufacturing organizations (CMOs) involved in Zegalogue fill-finish?
Requires NDA/CMC site data; not provided.
-
Do Zegalogue suppliers differ by country?
Requires country label disclosures and local batch release information; not provided.
